Table 6.
Studies | BP < 130/80 mm Hg (%) | HbA1c < 7% (%) | LDL-C < 2.6 mmol/l (%) | BP < 130/80 mm Hg, HbA1c < 7%, and LDL-C < 2.6 mmol/l (%) | BP < 140/90 mm Hg (%) | BP < 140/90 mm Hg, HbA1c < 7%, and LDL-C < 2.6 mmol/l (%) | Study design |
Xu[2] | 39.7 | A national wide, complex, multistage, probability sampling design | |||||
Gao[26] | 36.7 | National wide, community-based study | |||||
Ji[12] | 28.4 | 47.7 | 42.9 | 5.6 | Patients from endocrinology, cardiology, nephrology, and internal medicine clinics in Tier 1–3 hospitals | ||
Lv[33] | Newly diagnosed T2DM patients from Tier 1–3 hospitals | ||||||
<65 | 33.5 | 37 | 44.3 | 11.1 | |||
≥65 | 47.8 | 39.4 | 44.9 | 13.5 | |||
Xu[32] | 25.9 | 4.5 | 6 tertiary hospitals across Shaanxi province | ||||
Vinagre[35] | 31.7 | 56.1 | 37.9 | 12.1 | All patients with T2DM treated at the Catalan Health Institute, who were nearly free of charge | ||
<65 | 33.3 | 51.8 | 32.8 | 11.9 | |||
≥65 | 30.9 | 58.5 | 40.6 | 12.1 | |||
Male | 32 | 55.8 | 41.3 | 13.3 | |||
Female | 31.4 | 56.5 | 34.2 | 9.9 | |||
Braga[36] | 54 | 53 | 64 | 21 | Primary care physicians were instructed to enroll T2DM patients | ||
Wong ND[34] | 34.2–52.8 | 35–55.5 | 37–54.4 | 2.5–24.9 | NHANES 1999–2010 | ||
Our study | 27.8 | 26.5 | 42.6 | 4.1 | 60.9 | 8.5 | |
<65 | 29.3 | 25.5 | 41.6 | 4 | 63.4 | 8.4 | |
≥65 | 24.3 | 29 | 44.9 | 4.3 | 55.3 | 8.9 | |
Male | 26.7 | 26.1 | 46 | 4 | |||
Female | 29.2 | 27 | 38.3 | 4.2 |